BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $86,597,000 | +3.4% | 572,845 | -0.3% | 0.02% | +11.1% |
Q2 2022 | $83,749,000 | +34.1% | 574,770 | +9.2% | 0.02% | +63.6% |
Q1 2022 | $62,433,000 | -22.1% | 526,552 | -9.4% | 0.01% | -15.4% |
Q4 2021 | $80,132,000 | +3.7% | 581,474 | +4.5% | 0.01% | -7.1% |
Q3 2021 | $77,261,000 | +42.1% | 556,193 | -0.7% | 0.01% | +40.0% |
Q2 2021 | $54,352,000 | +47.1% | 559,865 | +3.6% | 0.01% | +42.9% |
Q1 2021 | $36,946,000 | -22.9% | 540,542 | -3.3% | 0.01% | -22.2% |
Q4 2020 | $47,910,000 | +29.0% | 558,974 | -2.1% | 0.01% | +12.5% |
Q3 2020 | $37,129,000 | -13.4% | 571,119 | -2.6% | 0.01% | -20.0% |
Q2 2020 | $42,887,000 | +140.1% | 586,616 | +11.8% | 0.01% | +100.0% |
Q1 2020 | $17,859,000 | -30.9% | 524,792 | +10.5% | 0.01% | -16.7% |
Q4 2019 | $25,850,000 | +26.5% | 474,843 | -3.1% | 0.01% | +20.0% |
Q3 2019 | $20,436,000 | +17.0% | 489,849 | +22.9% | 0.01% | +25.0% |
Q2 2019 | $17,460,000 | -11.9% | 398,721 | +3.5% | 0.00% | -20.0% |
Q1 2019 | $19,822,000 | +55.1% | 385,108 | +11.4% | 0.01% | +25.0% |
Q4 2018 | $12,780,000 | -1.7% | 345,633 | -0.2% | 0.00% | +33.3% |
Q3 2018 | $13,002,000 | +1.6% | 346,269 | +6.9% | 0.00% | 0.0% |
Q2 2018 | $12,802,000 | +63.6% | 323,923 | +6.6% | 0.00% | +50.0% |
Q1 2018 | $7,827,000 | +146.8% | 303,830 | +158.5% | 0.00% | +100.0% |
Q4 2017 | $3,172,000 | -27.7% | 117,556 | +0.1% | 0.00% | 0.0% |
Q3 2017 | $4,389,000 | +55.3% | 117,408 | +3.9% | 0.00% | 0.0% |
Q2 2017 | $2,826,000 | – | 113,027 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |